EH
CN
Home
Haisco
Group Profile
Subsidiary Profile
Production Base
Production Equipment
Production Capacity
Products
corporate Culture
Enterprise Philosophy
Employee Benefits
Employees
Enterprise Magazine
Contact Us
Product
Narcotic Analgesics
Endocrine System Drugs
Enteral Parenteral Nutrition Drugs
Neuropsychiatric Drugs
Cardiovascular Drugs
Tumor Related Drugs
Drugs For Digestive Liver Disease
Other
Innovative R&D
Innovative R&D
Our Science
Clinical Trial
Platform
Partnership
Investor
Stock Information
Investor Hotline
Contact Us
EH
CN
Haisco
Group Profile
Subsidiary Profile
Production Base
Production Equipment
Production Capacity
Products
corporate Culture
Enterprise Philosophy
Employee Benefits
Employees
Enterprise Magazine
Contact Us
Product
Narcotic Analgesics
Endocrine System Drugs
Enteral Parenteral Nutrition Drugs
Neuropsychiatric Drugs
Cardiovascular Drugs
Tumor Related Drugs
Drugs For Digestive Liver Disease
Other
Innovative R&D
Innovative R&D
Our Science
Clinical Trial
Platform
Partnership
Investor
Stock Information
Investor Hotline
Home
>
Haisco
>
Historical evolution
>
2019
07月03日
2022-01-07 15:15:57
四川海思科制药有限公司与印度Glenmark Pahrmaceuticals Limited公司签订关于阿瑞匹坦胶囊(有效预防化疗引起的呕吐反应)的合作协议,由海思科在中国大陆地区注册申请及销售该产品。
Returns